Inspire Medical Systems, Inc. (NYSE:INSP) CFO Sells $3,450,450.00 in Stock

Inspire Medical Systems, Inc. (NYSE:INSP) CFO Richard Buchholz sold 15,000 shares of Inspire Medical Systems stock in a transaction dated Wednesday, April 17th. The stock was sold at an average price of $230.03, for a total value of $3,450,450.00. Following the sale, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at approximately $6,503,178.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Inspire Medical Systems Price Performance

INSP opened at $241.12 on Friday. The stock’s 50-day moving average price is $202.84 and its 200 day moving average price is $183.76. Inspire Medical Systems, Inc. has a 12-month low of $123.27 and a 12-month high of $330.00.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Tuesday, February 6th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.53. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The firm had revenue of $192.51 million for the quarter, compared to analyst estimates of $186.75 million. During the same quarter in the prior year, the company earned $0.10 EPS. Inspire Medical Systems’s revenue was up 39.6% on a year-over-year basis. Analysts expect that Inspire Medical Systems, Inc. will post -0.35 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have issued reports on INSP shares. KeyCorp started coverage on Inspire Medical Systems in a report on Tuesday, February 6th. They issued an “overweight” rating and a $278.00 price target for the company. Jefferies Financial Group started coverage on Inspire Medical Systems in a report on Friday, January 19th. They issued a “buy” rating and a $245.00 price target for the company. Mizuho reissued a “buy” rating and issued a $250.00 price target on shares of Inspire Medical Systems in a report on Wednesday, March 27th. Morgan Stanley assumed coverage on Inspire Medical Systems in a report on Tuesday, March 19th. They issued an “overweight” rating and a $250.00 price target for the company. Finally, Truist Financial restated a “buy” rating and issued a $280.00 price objective on shares of Inspire Medical Systems in a research report on Wednesday, March 20th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, Inspire Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $271.29.

Hedge Funds Weigh In On Inspire Medical Systems

Several hedge funds have recently bought and sold shares of the company. Commonwealth Equity Services LLC lifted its stake in Inspire Medical Systems by 0.5% during the 1st quarter. Commonwealth Equity Services LLC now owns 6,774 shares of the company’s stock worth $1,585,000 after acquiring an additional 36 shares in the last quarter. Metropolitan Life Insurance Co NY raised its position in Inspire Medical Systems by 2.3% in the 4th quarter. Metropolitan Life Insurance Co NY now owns 1,734 shares of the company’s stock valued at $437,000 after purchasing an additional 39 shares in the last quarter. Mercer Global Advisors Inc. ADV raised its position in Inspire Medical Systems by 3.9% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 1,122 shares of the company’s stock valued at $364,000 after purchasing an additional 42 shares in the last quarter. Y Intercept Hong Kong Ltd raised its position in Inspire Medical Systems by 3.7% in the 2nd quarter. Y Intercept Hong Kong Ltd now owns 1,200 shares of the company’s stock valued at $390,000 after purchasing an additional 43 shares in the last quarter. Finally, Pathstone Family Office LLC raised its position in Inspire Medical Systems by 2.7% in the 3rd quarter. Pathstone Family Office LLC now owns 2,273 shares of the company’s stock valued at $403,000 after purchasing an additional 59 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.